| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |